MLL translocations, histone modifications and leukaemia stem-cell development.

Area of Science:

• Molecular Biology
• Epigenetics
• Hematology

Background:

• Translocations involving the mixed lineage leukaemia (MLL) gene are associated with a distinct subtype of acute leukaemia.
• These leukaemias often present with a poor prognosis.
• The MLL gene product is a DNA-binding protein crucial for gene expression regulation, including Hox genes, via histone H3 lysine 4 (H3K4) methylation.

Purpose of the Study:

• To investigate the functional consequences of MLL gene translocations in leukaemogenesis.
• To explore the role of MLL fusion proteins in the development of leukaemia stem cells.
• To understand the connection between chromatin modulation and stem cell biology in the context of leukaemia.

Main Methods:

• Analysis of MLL gene translocations in acute leukaemias.
• Assessment of H3K4 methyltransferase activity in MLL fusion proteins.
• Evaluation of the capacity of MLL fusion proteins to transform hematopoietic cells into leukaemia stem cells.

Main Results:

• Leukaemogenic MLL translocations result in MLL fusion proteins lacking H3K4 methyltransferase activity.
• MLL fusion proteins possess a potent ability to transform hematopoietic cells, generating leukaemia stem cells.
• A significant link exists between MLL's role as a chromatin modulator and the generation of leukaemia stem cells.

Conclusions:

• MLL fusion proteins drive leukaemogenesis by disrupting normal epigenetic regulation.
• The transformation of hematopoietic cells into leukaemia stem cells is a key mechanism in MLL-driven leukaemias.
• Epigenetic landscapes are critical determinants in both normal stem cell development and the pathogenesis of leukaemia.